Practitioner survey

Injection practices in facial filler treatments

This short anonymous survey (about 5 minutes) is for healthcare professionals who perform facial filler injections. It asks about your current practice and your views on a device concept that is still in development. It is conducted on behalf of a company developing injection devices. There are no right or wrong answers, and critical answers are as useful as positive ones. Your answers remain anonymous unless you choose to leave your email at the end. Thank you.

* Indicates required question

Q1. Country of practice *

Q3. On average, how many patients do you treat per month with hyaluronic acid or similar fillers? *

Fewer than 1010–4950–99100 or more

Q4. Which devices do you mainly use? *

NeedlesCannulasBoth, depending on the area

Q5. Have you ever experienced either of the following? *

Select all that apply.

A suspected intravascular injection that you detected before or during injectionA confirmed vascular occlusion in one of your patientsNeitherPrefer not to say

Q6. Which methods do you use to reduce the risk of injecting into a blood vessel? *

Select all that apply.

Q7. How concerned are you about the risk of intravascular injection? *

Not at all concernedSlightly concernedModerately concernedVery concerned

Q8. How concerned are you about intravascular injection when treating each area? *

Select one response per row.

Concept description

Concept under development: a sterile, single-use device that attaches to a standard Luer-lock syringe and needle. It is designed to show a visible signal if blood flows back into the device before the product is injected. It is designed for use with all types of injectable products, including hyaluronic acid fillers, biostimulators (such as calcium hydroxylapatite or poly-L-lactic acid) and autologous fat for lipofilling.

Q9. If it worked as described, how valuable would this be in your current practice? *

Q10. Would you be willing to replace your current needles/cannulas with this device if safety were improved? *

YesMaybeNoI would need clinical evidence first

Q11. For what share of your filler treatments would you expect to use it? *

Q12. Assume the device is an additional single-use item, bought per unit, on top of your normal syringe and needle. How likely would you or your practice be to buy it at each price? *

Select one response per price row. Read the price in your own currency.

Optional follow-up

Would you be open to a 20-minute follow-up conversation? If yes, leave your email. It will only be used to contact you for this conversation.

Follow-up conversation

Yes, I would be open to a follow-up conversation.

Email (optional)

	I don't treat this area	Not at all concerned	Slightly concerned	Moderately concerned	Very concerned
Lips
Nasolabial folds
Cheeks/midface
Nose
Temples
Tear trough
Chin

	Very unlikely	Unlikely	Unsure	Likely	Very likely
$10 / €9 / £8
$15 / €14 / £11
$20 / €18 / £15
$25 / €22 / £19